JAZZ

Russell 2000 below the 50-day average

Overview →

JAZZ News

About

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Bruce Cozadd
Country
Ireland
Leadership (11)
Bruce C. CozaddCo-Founder & Chairman
Philip L. JohnsonExecutive Vice President & Chief Financial Officer
Heidi MannaExecutive Vice President & Chief People Officer
Neena PatilExecutive Vice President & Chief Legal Officer
Patricia CarrSenior Vice President & Chief Accounting Officer
Renee D. GalaPresident, Chief Executive Officer & Director
John D. BluthHead of Investor Relations
Jed BlackSenior Vice President of Sleep & CNS Medicine
John MillerSenior Vice President of Corporate Strategy
Samantha PearceExecutive Vice President & Chief Commercial Officer
Robert IannoneExecutive Vice President, Chief Medical Officer and Global Head of Research & Development
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.